Press Releases

Rapid increase in purchasing teams expected at CPHI North America

One2Treat launches groundbreaking treatment-decision approach to clinical research and market access analysis

One2Treat, a new innovative start-up offering cutting edge digital health solutions, launches with a pioneering approach that addresses two of the most strategic challenges in the biopharma industry today - incorporating multiple outcomes that matter to patients into a single holistic treatment assessment while accelerating the delivery of new treatments to market. This method, refined through years of research and practical applications, not only enables a more patient-centric approach but also leads to consistent (often drastic) reductions in trial design sample sizes and time to market.

Emmes Endpoints Solutions Submits Duchenne Video Assessment Qualification Plan to FDA

SIRIO launches personalised women’s health platform at Vitafoods Europe

New ready-to-launch formulation range features premium branded ingredients, and targets issues as diverse as PMS, fertility, prenatal & postnatal care and menopause wellbeing.

Visit Watson-Marlow Fluid Technology Solutions at booth 3521 during INTERPHEX 2024 for exclusive technology previews and insights

Watson-Marlow Fluid Technology Solutions (WMFTS) will preview two new technologies at booth 3521 during INTERPHEX 2024, 16-18th April 2024, Javits Center, NYC, USA.

Alfa Chemistry Expands Offering of Polymer Fibers: Polyester Fiber, Polyamide Fiber, Aromatic Polyamide Fiber, and Polyacrylonitrile Fiber

CD Formulation Introduces Microneedle Patch Innovations for Enhanced Drug Delivery Efficiency

Quantum Pathology Enhances Digital Pathology Capabilities with the Adoption of PathAI's AISight Image Management System

Quantum Pathology, LLC, an independent pathology service provider in the United States, today announced the adoption of the AISight Image Management System, a leading end-to-end workflow and image management solution by PathAI. This strategic decision marks a significant step forward in Quantum Pathology's transition to digital pathology, leveraging the advanced capabilities of AISight to revolutionize its operations.

Alfa Chemistry’s MS and NMR Center Enables Fast, Cost-Effective Laboratory Analytical Testing

CD Formulation Incorporates Phase Separation Method for Microsphere Production

QDx Pathology Services Adopts Proscia’s Software To Improve Speed And Precision

Empowering its pathologists and advancing its practice with innovation

CD Formulation Offers Accurate and Reliable Impurity Determination for Biopharmaceutical Studies

Join Biopharma PEG Scientific Inc. at PEGS Boston Summit and TIDES USA 2024

Biopharma PEG Scientific Inc. will showcase its latest high-purity polyethylene glycol (PEG) derivatives and custom synthesis solutions at Booth No. 718 in PEGS Boston Summit 2024 and at TIDES USA 2024 at Booth No. 935.

Don't Miss: Huateng Pharma's Exhibit at CPHI Japan 2024

Hunan Huateng Pharmaceutical Co., Ltd is set to present its groundbreaking solutions at CPHI Japan 2024, showcasing expertise in PEG derivatives and CDMO services. Attendees are encouraged to visit Booth No. 4X-08 to explore cutting-edge offerings and engage with industry experts.

Alfa Chemistry Adds to Its Lineup of Derivatization Reagents for High-Performance Liquid Chromatography (HPLC)

AbbVie Launches Phase I Clinical Trial for ABBV-1882, Promising HIV Drugs Treatment Approach

The initiation of the phase I clinical trial for ABBV-1882 marks a significant milestone in the quest for novel HIV treatments. With its unique mechanism of action and potential to transform HIV management, ABBV-1882 represents a beacon of hope for individuals living with HIV and underscores AbbVie's unwavering commitment to advancing science for the benefit of patients worldwide.

New Syngene biologics manufacturing facility to be operational for US and European customers from mid-year

New facility includes 20KL of single use drug substance capacity coupled with drug product filling capacity of up to one million vials per day

CryoLogyx Completes £500k Seed Funding Round

* Funding round led by private UK business angels and the Wider Oxford Technology Angel Network * Investment to support commercialization of pre-plated, assay-ready, cryopreserved cells for drug discovery, diagnostic and cell therapy applications * CryoLogyx to showcase innovative cryopreservation technology at ELRIG Research & Innovation 2024

APM Steam Provides Expert Steam Trap Surveys to Document Operational Status and Provide Repair Recommendations Healthcare Facilities

Amerigo Scientific Releases Cyclic-di-GMP Assay to Simplify Cellular Function Analysis